Clinical significance of quantitative monitoring and mutational analysis ofBCR-ABL1transcript in Philadelphia chromosome positive B lymphoblastic leukemia-Reference-Cited by-同舟云学术

Clinical significance of quantitative monitoring and mutational analysis ofBCR-ABL1transcript in Philadelphia chromosome positive B lymphoblastic leukemia

Published:2015-08-06 Issue:2 Volume:57 Page:364-369
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zhang Linsheng,Ramjit Ruan T.,Hill Charles E.,Arellano Martha,Khoury H. Jean,Mann Karen P.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.1003059

Reference14 articles.

1. Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

2. Evidence-Based Guidelines for the Use of Tyrosine Kinase Inhibitors in Adults with Philadelphia Chromosome–Positive or Bcr-Abl–Positive Acute Lymphoblastic Leukemia: A Canadian Consensus

3. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

4. Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia;BMC Medical Genomics;2024-05-29

2. Management of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia;Pathogenesis and Treatment of Leukemia;2023

3. Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion;Case Reports in Hematology;2019-06-27

4. Lymphoblastic Leukemia/Lymphoma;Atlas of Bone Marrow Pathology;2018